Portfolio
 |
Centeo has designed a hand-held portable thermal control unit, which allows test samples to be exposed to multiple, controlled temperatures throughout the experiment protocol, saving time and increasing the accuracy of testing. No similar product is currently on the market. The technology has been developed over the last four years by CEO Dr Gabriela Juarez-Martinez and Dr Philipp Steinmann, CTO, and is set to transform thermal control protocols in the pharmaceutical and academic research sectors, where more than £500 million is routinely committed to the research and launch of each new drug. www.centeo.com |
 |
SFX Gel Audio™ Technology system turns virtually any solid surface into a seamless, high quality loudspeaker without the need for speaker cut-outs or grills – including glass, plastic, metal, wood, composites and even some fibrous materials.www.sfxtechnologies.com |
 |
Syntropharma develop products based on older generic medicines, which may be significantly improved by reformulation into transdermal (patch) systems.www.syntropharma.com |
 |
Lamellar Biomedical Ltd is a biotechnology company established to research, develop and commercialise the role of lamellasomes ® in serious hereditary disorders.www.lamellar.com |
 |
Actual Analytics use cutting-edge video analysis technology to automatically analyse behaviour – a crucial step in the development of new drugs treating diseases of the Central Nervous System (CNS), such as Alzheimer’s and Parkinson’s.Disorders of the nervous system affect 1 in 3 people during their lives, account for the largest single burden on the NHS and are often long-term disabling illnesses for the patient, their friends and family. At an estimated cost of over US$800m to take a new drug to market, Actual Analytics’ product will help customers cut costs and remove a significant bottleneck in the drug discovery pipeline.www.actualanalytics.com |